Today, Horizons Marijuana Life Sciences Idx USD shares closed at $7.71 after opening the day at $0.00. Intraday prices ranged from a low of $0.00 to a high of $0.00.
The price dipped -17.80% from the previous day’s close of $9.38.
Today across North America, the TSX Composite closed 0.39% at 20275.82, the S&P 500 closed 0.10% at 4109.11, the Dow Jones Industrial Average closed 0.30% at 33586.52 and the Nasdaq Composite closed -0.03% at 12084.36.
Horizons Marijuana Life Sciences Idx USD traded under HMMJ-U on the Toronto Stock Exchange (TSX).
Trading volume was 0 on 1 total trades. On average, Horizons Marijuana Life Sciences Idx USD has traded 312 shares over the last 5-days and 340 year-to-date.
The TSX overall saw 3,793 price advancers against 1,492 declines and 152 unchanged.
During the prior 52 weeks, HMMJ-U.TO has traded as high as $19.48 (March 29,2022) and low as $0.00 (April 10,2023). Moreover, in the last 12 months, Horizons Marijuana Life Sciences Idx USD’s shares have plummeted -59.16 percent, while they have eased -17.72% since the start of 2023.
Following today’s trading, Horizons Marijuana Life Sciences Idx USD has a market capitalization of $74.85 million on a float of 9,709 shares outstanding. Its annual EPS is $None.
Horizons Marijuana Life Sciences Idx USD is a None company headquartered in, None.
The Horizons Marijuana Life Sciences Index ETF seeks to replicate, to the extent possible, the performance of the North American Medical Marijuana Index, net of expenses. The North American Medical Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry.
Currently, Horizons Marijuana Life Sciences Idx USD has an average recommendation of “Strong Sell” based on 0.00 analysts according to Zacks. Currently, there are for the stock.
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
Recent Comments